ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
CYAB
Cyabra, Inc. Common Stock
There isn't enough reported data to score CYAB yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CYAB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Healthy |
CYAB's revenue and balance sheet are currently healthy, but its profitability and cash flow are weak.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CYAB PE Valuation
CYAB has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CYAB Forward outlook
There aren't enough analyst estimates for CYAB to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over CYAB in the latest year-over-year earnings comparison.
CYAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$0.24 | -443% |
| Q2 2024 | $0.20 | +900% |
| Q1 2024 | $0.22 | +$0.25 |
CYAB has swung to a loss: it lost $5.15 per share over the past year, after a profit the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CYAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.9M | +39% |
| Q1 2026 | $1.4M | +12% |
| Q4 2025 | $1.6M | +41% |
| Q3 2025 | $1.5M | +29% |
CYAB's revenue has grown year over year for eight quarters in a row: $2M last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -168% | +89 points |
| Q1 2026 | -836% | -515 points |
| Q4 2025 | -145% | +105 points |
| Q3 2025 | -145% | +43 points |
| Q2 2025 | -257% | N/A |
| Q1 2025 | -320% | N/A |
| Q4 2024 | -249% | N/A |
| Q3 2024 | -188% | N/A |
CYAB has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CYAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.4M | -$2M |
| Q1 2026 | -$2.6M | -$2.3M |
| Q4 2025 | -$1.6M | -$370K |
| Q3 2025 | -$2.7M | -$490K |
| Q2 2025 | -$423.1K | -$245.7K |
| Q1 2025 | -$254K | -$71.8K |
| Q4 2024 | -$1.3M | -$1.2M |
| Q2 2024 | -$177.4K | +$138.5K |
CYAB has burned cash in almost every quarter: −$9M over the past year, against −$4M the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CYAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +297% | +10.3M shares |
| 1 year | -0.2% | -23.6K shares |
| 3 years | +53% | +4.8M shares |
CYAB has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CYAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | 0.5x | Very low |
| Q1 2024 | 0.2x | Very low |
| Q4 2023 | -0.2x | Net Cash |
| Q3 2023 | -0.4x | Net Cash |
| Q2 2023 | -1.5x | Net Cash |
CYAB's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CYAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 1.5 | Oversold |
| Stochastic | 2.1 | Oversold |
CYAB's weekly RSI is 2 (oversold) and its Stochastic is 2 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CYAB PE vs Technology Sector
CYAB has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has stronger trend alignment. ASTS is above 1 of 5 weekly averages versus CYAB above 0 of 2.
CYAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.15 | 33% below |
| 20 week MA | $0.26 | 62% below |
CYAB is in a downtrend: it's below all two of its weekly moving averages, and 62% below its 20-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS has the edge over CYAB on returns for 2026, with the stronger performance.
CYAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $7.33 | $0.10 | -99% |
It's down 99% so far in 2026.